Plague is an infectious disease caused by bacterium Yersinia pestis. There are mainly three types of plague they are bubonic, pneumonic and septicemic. The symptoms of bubonic plague includes, swelling of lymph node, fever and weakness. In septicemic form the tissue turns black and die. Where in pneumonic form chest pain and shortness of breath is seen. The plague can be transmitted from handling of infected animal, flea bites, and droplets of infected person. The treatment of plague includes, vaccination and antibiotic therapy.
MARKET DYNAMICS
The key market drivers for Plague Market Includes, increasing prevalence of plague along with rising awareness about plague immunization across the globe. Moreover, rising adoption of companion animals is also expected to fuel market growth during forecast period. Whereas, strict regulatory approvals for drug and vaccine approval may restrain market growth during forecast period.
MARKET SCOPE
The "Plague Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Plague market with detailed market segmentation by Product and end user. The Plague Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Plague Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Plague Market is segmented on the basis of Product and end user. On the basis of product the market is segmented as, streptomycin, gentamycin, other antibiotics. And on the basis of end user the market is segmented as, hospitals, clinics and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Plague Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Plague Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Plague Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Plague Market in these regions.
MARKET PLAYERS
The report covers key developments in the Plague Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Plague Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Plague market in the global market. Below mentioned is the list of few companies engaged in the Plague Market.
The report also includes the profiles of key players in Plague Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- iBio, Inc.
- DynPort Vaccine Company LLC.
- Bayer Healthcare
- Pfizer, Inc.
- AstraZeneca
- Astellas Pharma
- Basilea pharmaceutica AG
- Abbott
- Baxter International
- Biocon
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.